209 related articles for article (PubMed ID: 23766903)
1. The role of magnesium in the management of cerebral vasospasm.
Odom MJ; Zuckerman SL; Mocco J
Neurol Res Int; 2013; 2013():943914. PubMed ID: 23766903
[TBL] [Abstract][Full Text] [Related]
2. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
[TBL] [Abstract][Full Text] [Related]
3. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: current status.
Wong GK; Chan MT; Gin T; Poon WS
Acta Neurochir Suppl; 2011; 110(Pt 2):169-73. PubMed ID: 21125466
[TBL] [Abstract][Full Text] [Related]
4. Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage.
Collignon FP; Friedman JA; Piepgras DG; Pichelmann MA; McIver JI; Toussaint LG; McClelland RL
Neurocrit Care; 2004; 1(4):441-8. PubMed ID: 16174947
[TBL] [Abstract][Full Text] [Related]
5. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
6. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M
J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
[TBL] [Abstract][Full Text] [Related]
7. Thick and diffuse cisternal clot independently predicts vasospasm-related morbidity and poor outcome after aneurysmal subarachnoid hemorrhage.
Aldrich EF; Higashida R; Hmissi A; Le EJ; Macdonald RL; Marr A; Mayer SA; Roux S; Bruder N
J Neurosurg; 2020 May; 134(5):1553-1561. PubMed ID: 32442971
[TBL] [Abstract][Full Text] [Related]
8. Potentials of magnesium treatment in subarachnoid haemorrhage.
van den Bergh WM; Dijkhuizen RM; Rinkel GJ
Magnes Res; 2004 Dec; 17(4):301-13. PubMed ID: 15726906
[TBL] [Abstract][Full Text] [Related]
9. Magnesium therapy within 48 hours of an aneurysmal subarachnoid hemorrhage: neuro-panacea.
Wong GK; Chan MT; Poon WS; Boet R; Gin T
Neurol Res; 2006 Jun; 28(4):431-5. PubMed ID: 16759446
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of premorbid hypertension and neurological status in aneurysmal subarachnoid hemorrhage: pooled analyses of individual patient data in the SAHIT repository.
Jaja BN; Lingsma H; Schweizer TA; Thorpe KE; Steyerberg EW; Macdonald RL;
J Neurosurg; 2015 Mar; 122(3):644-52. PubMed ID: 25554825
[TBL] [Abstract][Full Text] [Related]
11. Treatment of cerebral vasospasm after subarachnoid hemorrhage--a review.
Wu CT; Wong CS; Yeh CC; Borel CO
Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):215-22. PubMed ID: 15679131
[TBL] [Abstract][Full Text] [Related]
12. The impact of temporary clipping during aneurysm surgery on the incidence of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Malinova V; Schatlo B; Voit M; Suntheim P; Rohde V; Mielke D
J Neurosurg; 2018 Jul; 129(1):84-90. PubMed ID: 28946178
[TBL] [Abstract][Full Text] [Related]
13. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature.
Velat GJ; Kimball MM; Mocco JD; Hoh BL
World Neurosurg; 2011 Nov; 76(5):446-54. PubMed ID: 22152574
[TBL] [Abstract][Full Text] [Related]
14. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care.
Treggiari-Venzi MM; Suter PM; Romand JA
Neurosurgery; 2001 Feb; 48(2):249-61; discussion 261-2. PubMed ID: 11220367
[TBL] [Abstract][Full Text] [Related]
15. Vasospasm and delayed cerebral ischaemia in patients with spontaneous subarachnoid haemorrhage (aneurysmal and pretruncal non-aneurysmal): a centre's perspective.
Balasekaran N; Soelar SA; Anbarasen L; Cham CY; Rajandram R; Sia SF
Med J Malaysia; 2021 Jan; 76(1):17-23. PubMed ID: 33510103
[TBL] [Abstract][Full Text] [Related]
16. Clazosentan for Aneurysmal Subarachnoid Hemorrhage: An Updated Meta-Analysis with Trial Sequential Analysis.
Cho SS; Kim SE; Kim HC; Kim WJ; Jeon JP
World Neurosurg; 2019 Mar; 123():418-424.e3. PubMed ID: 30508597
[TBL] [Abstract][Full Text] [Related]
17. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
18. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans.
Thomas JE; Rosenwasser RH
Neurosurgery; 1999 Jan; 44(1):48-57; discussion 57-8. PubMed ID: 9894963
[TBL] [Abstract][Full Text] [Related]
19. Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database.
Tam AK; Ilodigwe D; Mocco J; Mayer S; Kassell N; Ruefenacht D; Schmiedek P; Weidauer S; Pasqualin A; Macdonald RL
Neurocrit Care; 2010 Oct; 13(2):182-9. PubMed ID: 20593247
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant therapy against cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Asano T; Matsui T
Cell Mol Neurobiol; 1999 Feb; 19(1):31-44. PubMed ID: 10079963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
